references
- Harris ED, Clinical features of rheumatoid arthritis, in: Textbook of Rheumatology, Kel-ley WN, Ruddy Harris ED, Sledge CB (Eds), pp. 898–932. W.B. Saunders, Philadelphia, (1997).
- Harris ED, Rheumatoid arthritis: pathophysiology and implications for therapy, New Engl J Med 322, 1277–89 (1990).
- Hochberg MC, Adult and juvenile rheumatoid arthritis: current epidemiologic concepts, Epidemiol Rev 1, 27–44 (1981).
- Taysi S, Polat F, Gul M, et al., Lipid peroxidation, some extracellular antioxidants and antioxidant enzymes in serum of patients with rheumatoid arthritis, Rheumatol Int 21, 200–4 (2002).
- Babior BM, Kipnes RS, Kurnutte JT, Biological defence mechanisms: The production of superoxide by leucocytes, a potential bactericidal agent, J Clin Invest 52, 741–6 (1973).
- Gutteridge JMC, Rowley DA, Halliwell B, Superoxide dependent formation of hydroxyl radicals in the presence of iron salts, Biochem J 199, 263–5 (1981).
- Robinson JJ, Watson F, Phelan M, et al., Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis, Ann Rheum Dis 52, 347–53 (1993).
- Dulray B, Elson CJ, Dieppe PA, Enhanced oxidative response of polymorphonuclear leukocytes from synovial fluids of patients with rheumatoid arthritis, Autoimmunity 1, 159–69 (1988).
- Nishimoto N, Yoshizaki K, Miyasaka N, et al., Treatment of rheumatoid with humanized anti-interleukin-6 receptor antibody, Arthritis Rheum 50, 1761–9 (2004).
- Holtby I, Cooper RG, Denton J, et al., Cytokine inter-relationships and their association with disease activity in arthritis, Brit J Rheumatol 31, 725–33 (1992).
- San RA, Taysi S, Erdem F, et al., Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus, Rheumatol Int 2 21, 149–52 (2002).
- Pemi P, Genovese M, Eugk E, et al., Definition, incidence and clinical description of flare in systemic lupus erythematosus, Arthritis Rheum 34, 937–43 (1991).
- Coğalgil S, Taysi S, Sialic acid, intercellular adhesion molecule-1 and rheumatoid arthritis: a study on the erythrocyte membrane, Clin Chem Lab Med 40, 356–60 (2002).
- Taysi S, Gul M, Sari RA, et al., Oxidant/Antioxidant status in serum of patients with systemic lupus erythematosus, Clin Chem Lab Med 40, 684–8 (2002).
- Steiner G, Tohidast-Akrad, Witzmann G, et al., Cytokine production bey synovial T cell in rheumatoid arthritis, Rheumatology 38, 202–13 (1999).
- Feldman M, Dower S, Brennan FM, The role of cytokines in normal and pathological situations, in: Cytokines in Autoimmunity, Brennan FM, Feldman M (Eds), pp. 1–24. RG Landes, Austin, Texas (1996).
- Koch AE, Kunkel SL, Strieter RM, Cytokines in rheumatoid arthritis, J Invest Med 43, 28–38 (1995).
- Houssiau FA, Devegelaer JP, van Damme J, et al., Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides, Arthritis Rheum 31, 784–8 (1988).
- Kruda T, Tanabe N, Sakatsume M, et al., Interleukin-2 levels are elevated in bone marrow serum of patients with mutilans-type rheumatoid arthritis, 21, 23–7 (2002).
- Wong WM, Vakis SA, Ayre KR, et al., Rheumatoid arthritis T cells produce Thl cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD29, Scand J Rheumatol 29, 282–7 (2000).